Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : MCAR -- Ignore unavailable to you. Want to Upgrade?

To: zgoodman who wrote (133)	1/30/1998 9:17:00 AM
From: Harvey DeWalt	Read Replies (1) \| Respond to of 467

I too, have doubled my position to 5,000 shares in MCAR recently .... here's what's happening ... 01) The company is likely adding a very strong, well-known personality to their board ... someone well recognized and respected in the Urology area ... I heard from a friend of mine that this doctor is also on the board of a major Fortune 500 pharmaceutical company! 02) They have been sought out recently by several name-brand, retail brokerage firms, eager to start talking about the company ... this may be because MedCare's moving onto NASDAQ 03) MedCare should meet it's expansion goals, comfortably. Bottom line? ... MCAR should do very well this year, *especially if trading and expansion continue the way they have been recently.*